Description
TREVIAMET Tablets 50mg/500mg (14’s) are a prescribed oral medication available at Gathimaini Pharmacy in Thika, Kenya, used for the comprehensive management of Type 2 Diabetes Mellitus. This fixed-dose combination contains Sitagliptin 50mg and Metformin Hydrochloride 500mg.
- Sitagliptin (a DPP-4 inhibitor) works by increasing the levels of incretin hormones, which helps the body produce more insulin when blood sugar is high and reduces sugar production by the liver.
- Metformin (a biguanide) primarily reduces the amount of glucose produced by the liver, decreases the absorption of glucose from the intestines, and improves the body’s sensitivity to insulin.
By combining these two mechanisms, TREVIAMET 50mg/500mg provides enhanced blood sugar control, particularly in adult patients whose diabetes is not adequately controlled by diet and exercise alone, or by Metformin or Sitagliptin individually. It is often initiated when a patient needs more intensive glycemic control. This medication helps to improve overall blood sugar levels, including fasting and post-meal glucose, reducing the risk of long-term diabetes complications. The pack size of 14 tablets is a common supply for this medication.
